Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QNN5 | ISIN: FR0014001PM5 | Ticker-Symbol: 1FO
Tradegate
23.01.25
11:14 Uhr
3,475 Euro
+0,100
+2,96 %
1-Jahres-Chart
HYDROGEN-REFUELING-SOLUTIONS Chart 1 Jahr
5-Tage-Chart
HYDROGEN-REFUELING-SOLUTIONS 5-Tage-Chart
RealtimeGeldBriefZeit
3,3653,46515:43
Actusnews Wire
693 Leser
Artikel bewerten:
(2)

HYDROGEN REFUELING SOLUTIONS (HRS): HRS OBTAINS THE SUPPORT OF THE BPI WITH A EUR 1.35 MILLION GRANT FOR INNOVATION AND INTERNATIONAL DEVELOPMENT

Finanznachrichten News

HRS OBTAINS THE SUPPORT OF THE BPI

WITH A €1.35 MILLION GRANT

FOR INNOVATION AND INTERNATIONAL DEVELOPMENT

Grenoble, 29 April 2024 - HRS, a French designer and manufacturer and European leader in hydrogen refueling stations, is proud to announce that it has received exceptional funding of €1.35 million from Bpifrance. This strategic financial support is aimed at accelerating the company's international expansion and stepping up its research and development activities, particularly in the field of large-capacity stations.

The funding consists of an €800,000 Innovation Loan with a 3-year grace period, and €550,000 in Business Development Assistance, repayable subject to certain conditions relating to the achievement of sales targets in the USA, demonstrating Bpifrance's renewed confidence in and commitment to HRS.

  • The Innovation Loan will enable our research and development teams to play a leading role in developing innovative technologies, while enhancing the performance and reliability of our facilities. These innovations are crucial if we are to adapt our stations to market trends towards heavy and intensive hydrogen mobility, as well as to the specific standards and climatic conditions in the United States and the Middle East.
  • The Assistance Prospection is a repayable grant that will strengthen our commercial capabilities in the United States, a market offering significant growth prospects for large-capacity hydrogen stations. In addition, HRS will also benefit from Bpifrance's International Project Guarantee, which will guarantee 50% of the equity invested in our future US subsidiary, with a maximum commitment of €2.1 million over three years.

With this financial support from Bpifrance, HRS aims to set up a subsidiary in the United States to address the North American market directly from the second half of 2024, marking a major step forward in its global expansion strategy in a market that enjoys strong regulatory and tax support.

According to a study published by the Fuel Cell and Hydrogen Energy Association (FCHEA)[1] , entitled "Road Map to a US Hydrogen Economy Full Report", the US hydrogen mobility market is expected to grow rapidly, with a projected 4,300 stations specifically for the needs of Heavy Duty Vehicles (HDVs). According to the same report, by 2030, 1.2 million FCEVs[2] are expected to be sold in the USA. Finally, the report shows that California has set ambitious targets for creating a network of 1,000 hydrogen filling stations by 2030.

More recently, in October 2023, the Biden administration announced a historic $7 billion investment in 7 regional Clean hydrogen hubs[3]. These hubs will catalyse more than $50 billion in private and public investment and aim to produce more than 3 million tonnes of green hydrogen per year. The Hydrogen Shot goal will aim to reduce the cost of producing green hydrogen to $1 per kilogram in the next 10 years, by supporting electrolysis technologies and improving manufacturing and recycling.

Finally, in March 2024, the US Department Of Energy (DOE) announced a $750 million investment in 52 projects in 24 states to reduce the cost of green hydrogen and strengthen US leadership in this growing sector[4] .

Hassen Rachedi, Founder and CEO of HRS said: "This significant financial support from the BPI is an exceptional validation of our growth strategy and long-term vision. We are grateful to the BPI for their renewed confidence and continued partnership. This additional funding will enable us to accelerate our strategic initiatives and consolidate our position as market leader in hydrogen stations. This strategic decision demonstrates the BPI's unwavering confidence in HRS's growth prospects. The extension of this partnership not only validates our strategic vision, but also testifies to the solid growth trajectory we have mapped out. The BPI shares our belief that we are on the verge of making significant progress, both domestically and internationally."

ABOUT HRS

Founded in 2004, Hydrogen-Refueling-Solutions (HRS), formerly TSM, is a pioneer in hydrogen mobility in Europe. With its unique know-how and experience, HRS has been committed for over 10 years to decarbonising transport by designing and manufacturing a complete range of hydrogen refuelling stations that can be used by all types of fuel cell vehicles and are perfectly suited to the needs of a fast-growing European market.

At its new site in Champagnier, HRS have the mass production capacity to assemble up to 180 units a year in a record time of just 8 weeks.

In the 2022/2023 financial year, HRS generated sales of €30.1m. At 31 December 2023, HRS had 142 employees. ISIN code: FR0014001PM5 - mnemonic: ALHRS

CONTACTS

Investor Relations
ACTUS finance & communication
Grégoire SAINT-MARC
hrs@actus.fr
Tel. 01 53 67 36 94
Financial press relations
ACTUS finance & communication
Deborah SCHWARTZ
hrs-presse@actus.fr
Tel. 01 53 67 36 36
Corporate press relations
ACTUS finance & communication
Anne-Charlotte DUDICOURT
hrs-presse@actus.fr
Tel.: 01 53 67 36 32

[1] https://www.fchea.org/us-hydrogen-study

[2] Fuel Cell Electric Vehicles

[3] https://www.whitehouse.gov/briefing-room/statements-releases/2023/10/13/biden-harris-administration-announces-regional-clean-hydrogen-hubs-to-drive-clean-manufacturing-and-jobs/

[4] https://www.energy.gov/articles/biden-harris-administration-announces-750-million-support-americas-growing-hydrogen?utm_medium=email&utm_source=govdelivery

------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: l25tlJVtlGjJlWlwZcpqbmiZZpqVmJGWZmKVm2aclcqdnXFmx5tnmZyXZnFmmGxs
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-85376-2024_04_29-soutien-bpi-hrs-vdef-en-gb.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
© 2024 Actusnews Wire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.